Harrow, Inc.

HROW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $4.0M $8.9M $2.7M $8.2M $15.6M $10.0M $146.2K $291.5K
Accounts Receivable $1.5M $2.9M $840.0K $81.0K — — — —
Inventory $2.2M $1.8M $1.4M $373.0K — — — —
Total Current Assets $8.8M $14.8M $5.9M $9.1M $15.7M $10.7M $161.0K $352.0K
Property, Plant & Equipment $6.2M $7.3M $2.7M $243.0K $26.9K $12.5K $0 $338
Goodwill $2.2M $2.2M $2.5M $332.0K — — — —
Intangible Assets (Excl. Goodwill) $2.9M $3.0M $3.1M $611.0K — — — —
Total Assets $23.9M $27.2M $14.1M $10.2M $15.8M $10.7M $161.0K $352.3K
Liabilities
Accounts Payable $3.9M $3.5M $3.4M $787.0K $311.9K $286.7K $218.6K $73.6K
Total Current Liabilities $5.8M $9.9M $5.4M $1.6M $650.6K $709.6K $1.9M $335.0K
Long-Term Debt $23.5M — — — — — — —
Total Liabilities $21.3M $20.8M $15.5M $2.1M $650.6K $709.6K $1.9M $1.4M
Stockholders' Equity
Retained Earnings $-88.8M $-76.9M $-57.8M $-41.9M $-31.7M — — —
Total Stockholders' Equity $2.6M $6.4M $-1.4M $8.2M $15.1M $10.0M $-1.7M $-1.0M
← Newer Page 2 of 2 Older →